| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.04 | 0.8 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | 0.041 | 0.8 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |